A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma

Name: A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
License: Public Domain

Seagen Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

lymphoma, b-cell, lymphoma, large b-cell, diffuse, lymphoma, non-hodgkin, lymphoma, t-cell

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 238097
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.